Equity Research, Broker Reports, and media content on Oxford Biomedica

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Oxford Biomedica
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Oxford Biomedica

Company Profile

  • Personnel
  • John Dawson, CEO
  • Stuart Paynter, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Oxford Biomedica. We currently have 133 research reports from 8 professional analysts.

  • Open: 771p
  • Range Today: 771/790p
  • 52 Week: 400/792p
  • Daily Volume: 6.7k
  • Daily Liquidity: (0.01%)
  • # Shares: 76.9m
  • Market Cap: £593.0m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
01Jun20 07:00 RNS Dr Roch Doliveux appointed Non-Executive Chairman
28May20 12:16 RNS Clinical & Commercial Supply Agreement with AZ
27May20 11:26 RNS Director Dealings / Market Share Purchase
22May20 17:28 RNS 2019 Annual report and Accounts & AGM Notification
20May20 14:34 RNS Holding(s) in Company
13May20 18:02 RNS Holding(s) in Company
13May20 07:00 RNS OXB receives approval for first two Oxbox suites
  • Frequency of research reports

     

  • Research reports on

    Oxford Biomedica

  • Providers covering

    Oxford Biomedica